(NasdaqGM:TECX), WATERTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in […]
(NasdaqGM:RZLV), Deal to Add approximately $70M Revenue and is immediately EBITDA-accretive, Expanding “Brain Commerce” Footprint Across US, UK & EMEA Advances roll-up strategy for upselling traditional search platforms and strengthens Rezolve's enterprise AI footprint across global markets A strategic 'return' for CEO Daniel Wagner, whose early product discovery technology underpins part of Crownpeak's platform, Unlocking
(NASDAQ:TKLF), Tokyo, Japan, Dec. 01, 2025 (GLOBE NEWSWIRE) — Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards, trendy toys as well as other products in Hong Kong, Japan, North America, Thailand, Vietnam and the
(NASDAQ:PODC), Premieres to Over 125 Million Pay Cable Subscribers and Free Streaming Viewers Via Envoy TV and Envoy FAST Channels, Dr. Phil Combined Social Following Tops 27 Million Network Debuts With More Than 200 Podcasts and 15,000 Hours of Premium Library Content Drawn From the Combined Catalogs of PodcastOne and Envoy Media Co. LOS ANGELES,
(HKSE:6855),(NasdaqGM:AAPG), ROCKVILLE, Md. and SUZHOU, China, Dec. 01, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company“), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that Chairman &
(NASDAQ:SLRX), Salarius subsidiary Decoy Therapeutics' influenza fusion inhibitors, designed using its proprietary IMP3ACT(TM) platform, show excellent in silico free energy binding to the viral target entry protein, supporting potential for anti-flu activity IMP3ACT's demonstrated capability to create a single antiviral therapeutic against influenza, COVID and RSV has potential to position Salarius to address large existing
(NasdaqGM:NEUP), BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders, today issued the following statements to address what Neuphoria strongly believes is a campaign from Lynx1 Master Fund
(CNSX:CQX),(OTC US:IMIMF),(Other OTC:IMIMF),(Boerse Frankfurt – Freiverkehr:3MX0),(CNSX:CQX.CN),(Boerse Frankfurt – Freiverkehr:3MX0.F), VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company“) is pleased to announce it has entered into a strategic partnership with U.S. based Exploration Technologies Inc. (“ExploreTech“) to deploy generative artificial
(NASDAQ:CRNC), BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that the Company will participate in the Raymond James TMT and Consumer Conference on Monday, December 8, 2025, in New York City. Cerence AI's President and Chief Executive Officer, Brian
(PinkSheets:PTOP),(Pinksheets:PTOP),(Pinksheets:PTOPD),(PinkSheets:PTOPD), CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Peer To Peer Network (OTC: PTOP) today issued a summary of its November 27th investor call, where newly appointed division president Derek McCarthy outlined the Company's AI-driven strategy for transforming investor communications and engagement. The Company opened the call by expressing its deep appreciation for the